---
run_id: halo-evidence-vs-diagnosis-validation-v12-substrate-workflow-06
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: substrate_workflow
run_number: 6
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 603
prompt_source: condition packet (substrate_workflow) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: a substrate preamble plus the full public-safe text of three reviewed source cards, then the frozen Advisor prompt - see run-packet.md
source_packet_sha256: b6cd135fd92e629c778a8282ec7993f44f89675e5f6dceea2232399cd10f2424
condition_packet_sha256: b6cd135fd92e629c778a8282ec7993f44f89675e5f6dceea2232399cd10f2424
output_file: model-outputs/substrate_workflow-06.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - substrate_workflow (run 06)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `substrate_workflow`, run 6 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 603, on the frozen condition packet.

## Output

I recommend that the CEO commit to the **Demand Cleanroom**.

### Rationale
The current perceived success of PlanPilot is highly susceptible to the **halo effect** (BK-0048-card-001). Because expansion bookings rose and renewals closed early, the executive team has attributed specific positive traits to the product team—describing them as "focused," "commercially disciplined," and "aligned." However, the evidence suggests these traits are being projected onto the team based on a performance signal that may be artificial.

The "strong quarter" is heavily contaminated by two factors:
1. **Financial Incentives:** Expansion dollars are tied to temporary bundle pricing (a price-driven signal, not a value-driven one).
2. **Narrative Bias:** Customer enthusiasm was collected *after* sales told buyers PlanPilot would be the roadmap centerpiece, creating a feedback loop based on future promise rather than current utility.

While the *Case Evidence Review* would provide a "diagnosis" of product failure (BK-0001-card-001), it does not solve the immediate budget risk: the board is locking a budget based on the belief that PlanPilot is driving growth. The **Demand Cleanroom** is the only option that isolates the performance signal from the product's actual value by removing the bundle-price incentive and the roadmap pitch. This is a rigorous application of **validated learning** (BK-0007-card-001), as it seeks empirical evidence from actual customer behavior (signed intent and renewal objections) rather than "vanity" metrics like usage spikes or enthusiastic comments.

### The Strongest Reason Against
The Demand Cleanroom is the most "expensive" option in terms of short-term revenue risk. By withholding bundle pricing and roadmap pitches from a matched set of accounts, you intentionally risk lowering the expansion booking rate for that cohort in the immediate term. This may create a negative performance signal during the exact window when the board is deciding on next year's budget.

### Evidence That Would Change My Mind
I would change this recommendation if the **Case Evidence Review** revealed that the "abandonment" in the public sector was a trivial UI/documentation issue rather than a fundamental failure of the tool's logic. If the product is fundamentally sound and only lacks "explainability," the risk shifts from *market validation* (Demand Cleanroom) to *execution/enablement* (Adoption Quality Sprint). However, given that regional administrators are already planning to remove the product from contracts—a signal that precedes official churn reporting—the evidence suggests a value-proposition failure, making the Demand Cleanroom the priority.
